NATAP: DDW Reports

[Guest guest]

DDW

Digestive Disease Week

May 21-24, 2006, Los Angeles

"...the most real-time, comprehensive, independent conference coverage on the internet..."

 These are reports from DDW so far posted on the NATAP website, others will be added.

     •     "Week 12 Antiviral Activity of Higher Doses of albumin interferon alfa-2b (Albuferon) Combined with Ribavirin in Non-responders to Prior Interferon Based Therapy for Chronic HCV-Infection" - (05/25/06)

 

     •     Entecavir (ETV) Demonstrates Consistent Responses Throughout Baseline Disease and Demographic Subgroups for the Treatment of Lamivudine-Refractory (LVD-ref) HBeAg(+) Patients with Chronic Hepatitis B - (05/25/06)

 

     •     Final Analysis of Virological Outcomes and Resistance During 5 Years of adefovir Dipivoxil Monotherapy in HBeAg-Negative Patients - (05/25/06)

 

     •     96-Week Viral Suppression Data From Two Studies Presented For BARACLUDE (entecavir) In Chronically-Infected Hepatitis B Patients - (05/24/06)

 

     •     Results from a Cost-Effectiveness Study Demonstrate Positive Economic Impact with PEGASYS Treatment - (05/24/06)

 

     •     G-CSF is safe and improves adherence and SVR in HCV patients with genotype 1 who develop Peg-IFNa-2b related severe neutropenia - (05/24/06)

 

     •     African-Americans' response to Interferon: preliminary results from Virahep C Study - (05/24/06)

 

     •     VX-950 HCV Protease Inhibitor + Pegasys/RBV: 28 days study results in treatment-naive - (05/24/06)

 

     •     ViroPharma Announces Presentation of HCV-796 Phase 1b Data at Digestive Disease Week - (05/23/06)

 

     •     HCV Protease ITMN 191, In Vitro Resistance - - (05/23/06)

 

     •     High Dose Albuferon -early data - (05/23/06)

 

     •     Hepatitis Patients at Risk for Accidental Acetaminophen Toxicity - (05/23/06)

 

     •     Reliable early prediction of viral relapse by detection of minimal residual hepatitis C viremia at treatment week 12 with Sensitive HCV Viral load Test - (05/22/06)

 

     •     High Prevalence of Hepatitis C Virus Infection Among Russian Immigrants in the New York City Metropolitan Area: Results of A Community-Based Screening Program - (05/22/06)

 

     •     Noninvasive Biomarker Test for Fatty Liver - (05/22/06)

 

     •     Researchers Report Results for 28-day Phase II Study of VX-950 in Combination with Pegylated Interferon and Ribavirin in Hepatitis C Patients - (05/22/06)

 

     •     The prevalence of metabolic syndrome (53%) in veterans with chronic hepatitis C virus - (05/22/06)